Cargando…

Personalized hypertension treatment recommendations by a data-driven model

BACKGROUND: Hypertension is a prevalent cardiovascular disease with severe longer-term implications. Conventional management based on clinical guidelines does not facilitate personalized treatment that accounts for a richer set of patient characteristics. METHODS: Records from 1/1/2012 to 1/1/2020 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yang, Huerta, Jasmine, Cordella, Nicholas, Mishuris, Rebecca G., Paschalidis, Ioannis Ch.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979505/
https://www.ncbi.nlm.nih.gov/pubmed/36859187
http://dx.doi.org/10.1186/s12911-023-02137-z
_version_ 1784899740448587776
author Hu, Yang
Huerta, Jasmine
Cordella, Nicholas
Mishuris, Rebecca G.
Paschalidis, Ioannis Ch.
author_facet Hu, Yang
Huerta, Jasmine
Cordella, Nicholas
Mishuris, Rebecca G.
Paschalidis, Ioannis Ch.
author_sort Hu, Yang
collection PubMed
description BACKGROUND: Hypertension is a prevalent cardiovascular disease with severe longer-term implications. Conventional management based on clinical guidelines does not facilitate personalized treatment that accounts for a richer set of patient characteristics. METHODS: Records from 1/1/2012 to 1/1/2020 at the Boston Medical Center were used, selecting patients with either a hypertension diagnosis or meeting diagnostic criteria (≥ 130 mmHg systolic or ≥ 90 mmHg diastolic, n = 42,752). Models were developed to recommend a class of antihypertensive medications for each patient based on their characteristics. Regression immunized against outliers was combined with a nearest neighbor approach to associate with each patient an affinity group of other patients. This group was then used to make predictions of future Systolic Blood Pressure (SBP) under each prescription type. For each patient, we leveraged these predictions to select the class of medication that minimized their future predicted SBP. RESULTS: The proposed model, built with a distributionally robust learning procedure, leads to a reduction of 14.28 mmHg in SBP, on average. This reduction is 70.30% larger than the reduction achieved by the standard-of-care and 7.08% better than the corresponding reduction achieved by the 2nd best model which uses ordinary least squares regression. All derived models outperform following the previous prescription or the current ground truth prescription in the record. We randomly sampled and manually reviewed 350 patient records; 87.71% of these model-generated prescription recommendations passed a sanity check by clinicians. CONCLUSION: Our data-driven approach for personalized hypertension treatment yielded significant improvement compared to the standard-of-care. The model implied potential benefits of computationally deprescribing and can support situations with clinical equipoise. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-023-02137-z.
format Online
Article
Text
id pubmed-9979505
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99795052023-03-03 Personalized hypertension treatment recommendations by a data-driven model Hu, Yang Huerta, Jasmine Cordella, Nicholas Mishuris, Rebecca G. Paschalidis, Ioannis Ch. BMC Med Inform Decis Mak Research Article BACKGROUND: Hypertension is a prevalent cardiovascular disease with severe longer-term implications. Conventional management based on clinical guidelines does not facilitate personalized treatment that accounts for a richer set of patient characteristics. METHODS: Records from 1/1/2012 to 1/1/2020 at the Boston Medical Center were used, selecting patients with either a hypertension diagnosis or meeting diagnostic criteria (≥ 130 mmHg systolic or ≥ 90 mmHg diastolic, n = 42,752). Models were developed to recommend a class of antihypertensive medications for each patient based on their characteristics. Regression immunized against outliers was combined with a nearest neighbor approach to associate with each patient an affinity group of other patients. This group was then used to make predictions of future Systolic Blood Pressure (SBP) under each prescription type. For each patient, we leveraged these predictions to select the class of medication that minimized their future predicted SBP. RESULTS: The proposed model, built with a distributionally robust learning procedure, leads to a reduction of 14.28 mmHg in SBP, on average. This reduction is 70.30% larger than the reduction achieved by the standard-of-care and 7.08% better than the corresponding reduction achieved by the 2nd best model which uses ordinary least squares regression. All derived models outperform following the previous prescription or the current ground truth prescription in the record. We randomly sampled and manually reviewed 350 patient records; 87.71% of these model-generated prescription recommendations passed a sanity check by clinicians. CONCLUSION: Our data-driven approach for personalized hypertension treatment yielded significant improvement compared to the standard-of-care. The model implied potential benefits of computationally deprescribing and can support situations with clinical equipoise. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-023-02137-z. BioMed Central 2023-03-01 /pmc/articles/PMC9979505/ /pubmed/36859187 http://dx.doi.org/10.1186/s12911-023-02137-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Hu, Yang
Huerta, Jasmine
Cordella, Nicholas
Mishuris, Rebecca G.
Paschalidis, Ioannis Ch.
Personalized hypertension treatment recommendations by a data-driven model
title Personalized hypertension treatment recommendations by a data-driven model
title_full Personalized hypertension treatment recommendations by a data-driven model
title_fullStr Personalized hypertension treatment recommendations by a data-driven model
title_full_unstemmed Personalized hypertension treatment recommendations by a data-driven model
title_short Personalized hypertension treatment recommendations by a data-driven model
title_sort personalized hypertension treatment recommendations by a data-driven model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979505/
https://www.ncbi.nlm.nih.gov/pubmed/36859187
http://dx.doi.org/10.1186/s12911-023-02137-z
work_keys_str_mv AT huyang personalizedhypertensiontreatmentrecommendationsbyadatadrivenmodel
AT huertajasmine personalizedhypertensiontreatmentrecommendationsbyadatadrivenmodel
AT cordellanicholas personalizedhypertensiontreatmentrecommendationsbyadatadrivenmodel
AT mishurisrebeccag personalizedhypertensiontreatmentrecommendationsbyadatadrivenmodel
AT paschalidisioannisch personalizedhypertensiontreatmentrecommendationsbyadatadrivenmodel